Delivery Order SPE2DB24D2003-SPE2DB25FXLP3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,573.79 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement within AmerisourceBergen's broader federal contract portfolio. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $11,592.97 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the place of performance for this transaction. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections, with a contract value of $6,577.97 and a completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 31, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order, which falls under the company's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens with a ceiling value of $1,088.36. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded through open competition. This delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,323.06 on August 13, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $11,395.71 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen medication, with a completion date of July 23, 2025. This non-set-aside, firm fixed-price contract reflects a competitively awarded delivery order supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems, delivering...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens valued at $7,129.50. This is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and no set-aside designation was used in the award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a competitively awarded contract, this order...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.57 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive award under the company's existing indefinite delivery contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's medical...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLP3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,717.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medications and medical commodities to support federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Mounjaro delivery order reflects the company's role in fulfilling specialty pharmaceutical requirements within the broader DLA Medical Supply Chain, which encompasses diabetes medications, neurological treatments, and other therapeutic products essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/11/25 |